Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Ann Pharmacother. 2008 Nov 25;43(1):28–35. doi: 10.1345/aph.1L210

Table 1.

Characteristics at Enrollment of Patients Newly Colonized with Pseudomonas aeruginosa

Patient Characteristic MDR Pseudomonas (n = 20) Non-MDR Pseudomonas (n = 55) p Value
Age, y (mean ± SD) 61 ± 14 63 ± 13 0.45
Male (%) 13 (65) 23 (42) 0.08
ICU (%)
 medical 12 (60) 19 (35) 0.15
 surgical, scheduled 6 (30) 25 (45)
 surgical, nonscheduled 2 (10) 11 (20)
Chronic respiratory disease 5 (25) 11 (20) 0.75
Diabetes mellitus 5 (25) 8 (15) 0.31
Cancer 3 (15) 12 (22) 0.75
Immunosuppression 4 (20) 4 (7) 0.20
Days of hospitalization prior to ICU admission, median (25–75% percentile) 0 (0–1) 0 (0–2) 0.70
Days of hospitalization prior to first positive culture, median (25–75% percentile) 12.5 (5–31) 9 (3–15) 0.052
Days of ventilation prior to first positive culture, median (25–75% percentile) 10 (5–23.5) 5 (3–11) 0.015
APACHE II at ICU admission (mean ± SD) 26 ± 8 23 ± 7 0.12
SAPS II at ICU admission (mean ± SD) 46 ± 14 44 ± 16 0.60
ARDS at enrollment 3 (15) 2 (4) 0.11
ICU days, median (25–75% percentile) 30 (17–55) 20 (11–32) 0.02
Hospital days, median (25–75% percentile) 37 (28.5–72) 34 (21–47) 0.046

APACHE = Acute Physiology and Chronic Health Evaluation; ARDS = acute respiratory distress syndrome; ICU = intensive care unit; MDR = multidrug-resistant; SAPS = Simplified Acute Physiology Score.